IsoFlow Overview
- Founded
- 2001
- Status
- Out of Business
- Latest Deal Type
- Out of Business
IsoFlow General Information
Description
Developer of a drug infusion system for the people suffering from cancer. The company develops and markets an endovascular device which provides direct drug delivery to tumors and other delivery applications.
Contact Information
Website
Ownership Status
Out of Business
Financing Status
Formerly Angel backed
Primary Industry
Therapeutic Devices
Primary Office
- 4960 Almaden Expressway
- San Jose, CA 95118
- United States
IsoFlow Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Out of Business | 01-May-2016 | 00.000 | Completed | Out of Business | ||
| 2. Angel (individual) | 17-Dec-2010 | 00000 | 00.000 | Completed | Generating Revenue | |
| 1. Angel (individual) | 11-Jan-2008 | $1.68M | $1.68M | Completed | Generating Revenue |
IsoFlow Executive Team (1)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Robert Goldman | Co-Founder, President, Chief Technology Officer, Chief Executive Officer & Chairman |
IsoFlow Board Members (2)
| Name | Representing | Role | Since |
|---|---|---|---|
| Joe Maemone | IsoFlow | Board Member | 000 0000 |
| Robert Goldman | Self | Co-Founder, President, Chief Technology Officer, Chief Executive Officer & Chairman | 000 0000 |